Lgt Financial Advisors LLC Pfizer Inc Transaction History

Lgt Financial Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$25.89 - $29.73 $23,948 - $27,500	-925 Reduced 0.76%	121,090 $3.36 Billion
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $14,528 - $18,870	-556 Reduced 0.45%	122,015 $3.51 Billion
Q3 2023 Nov 01, 2023	SELL	$32.09 - $37.51 $736,401 - $860,779	-22,948 Reduced 15.77%	122,571 $4.07 Billion
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $567,589 - $656,688	15,714 Added 12.11%	145,519 $5.34 Billion
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $297,355 - $387,112	7,549 Added 6.17%	129,805 $5.3 Billion
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $5.1 Million - $6.66 Million	122,256 New	122,256 $6.26 Billion

3,267

3.73B

74.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Lgt Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Lgt Financial Advisors LLC with notifications on news.